Project cooperationUpdated on 7 May 2026

AI‑Driven Hantavirus Biosafety & Operational Risk Simulator for Extreme Environments

Founder & Independent Researcher – EU‑Recognised SME at TORMENTA‑IA3, SL

Madrid, Spain

About

This platform is an AI‑driven Hantavirus scenario simulator designed to support operational decision‑making, biosafety planning, and crisis‑management preparedness in remote or extreme environments such as maritime vessels, polar routes, research stations, and isolated infrastructures. The system does not perform medical diagnosis. Instead, it provides computational modelling, environmental reasoning, and multi‑AI consensus analysis to help operators anticipate risks and coordinate responses.

Core Capabilities

  • Simulation of Hantavirus outbreak scenarios as computational models (non‑clinical)

  • AI‑based reasoning for containment strategies, resource allocation, and operational routing

  • Integration of environmental telemetry, human‑mobility patterns, and logistical constraints

  • Digital Twin engine for vessels or remote facilities to test response strategies in real time

  • Multi‑AI consensus engine for high‑uncertainty decision‑support

  • Fully aligned with EU AI Act boundaries and outside the scope of medical device regulation

Applications

  • Maritime operations and expedition logistics

  • Remote scientific stations

  • Civil protection and emergency coordination

  • Crisis‑response training and preparedness

  • Biosafety planning in isolated infrastructures

Looking For

  • Partners for operational pilots in maritime or remote environments

  • Collaboration on sensor integration, telemetry, and early‑warning systems

  • Expertise in AI ethics, governance, and safety frameworks

  • Participation in Horizon Europe consortia (Clusters: Civil Security, Digital, Space, Climate Adaptation)

Topic

  • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
  • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
  • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
  • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
  • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
  • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
  • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients

Type

  • Consortium/Coordinator seeks Partners
  • Offering Expertise to Consortias

Organisation

TORMENTA‑IA3, SL

Company (SME)

Madrid, Spain

Similar opportunities